Eckert & Ziegler SE (MIL:1EUZ) 3-Year EPS without NRI Growth Rate : 9.30% (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Eckert & Ziegler SE 3-Year EPS without NRI Growth Rate?

Eckert & Ziegler SE's EPS without NRI for the three months ended in Sep. 2024 was €0.46.

During the past 12 months, Eckert & Ziegler SE's average EPS without NRI Growth Rate was 7.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 9.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 17.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Eckert & Ziegler SE was 70.30% per year. The lowest was -17.60% per year. And the median was 10.20% per year.

Competitive Comparison of Eckert & Ziegler SE's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, Eckert & Ziegler SE's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eckert & Ziegler SE's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's 3-Year EPS without NRI Growth Rate falls into.

Eckert & Ziegler SE 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Eckert & Ziegler SE (MIL:1EUZ) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Eckert & Ziegler SE 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Eckert & Ziegler SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (MIL:1EUZ) » Definitions » 3-Year EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

EUZd:UK 0NZY:UK EUZ:Germany

Address

Robert-Rossle-Street 10, Berlin, BB, DEU, 13125

Website

https://www.ezag.com

Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.

Eckert & Ziegler SE Headlines

No Headlines